CD68 and CR3/43 immunohistochemical expression in secretory meningiomas

Neurosurgery

Volumn 57, Issue 3, 2005, Pages 551-556

  Caffo, Mariella ^a   Caruso, Gerardo ^a   Germanò, Antonino ^a   Galatioto, Salvatore ^a   Meli, Francesco ^a   Tomasello, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

CD68; CR3 43; Immunohistochemistry; Macrophages; Major histocompatibility complex Class II; Secretory meningiomas

Indexed keywords

CD68 ANTIGEN; CR3 ANTIGEN; CR4 ANTIGEN; HLA ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BENIGN TUMOR; BRAIN EDEMA; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; MACROPHAGE; MALE; MENINGIOMA; MICROGLIA; MONONUCLEAR CELL; PRIORITY JOURNAL; PSAMMOMA BODY; PSEUDOPSAMMOMA BODY; QUANTITATIVE HISTOCHEMISTRY; SECRETORY MENINGIOMA; TUMOR VASCULARIZATION;

AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE-1 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; MENINGIOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 24344436780     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000170440.32720.77     Document Type: Article

References (27)

1. Alguacil-Garcia A, Pettigrew NM, Sima AAF: Secretory meningioma: A distinct subtype of meningioma. Am J Surg Pathol 10:102-111, 1986.
2. Asai J, Suzuki R, Fujimoto T, Suzuki T, Nagakawa N, Nagashima G, Miyo T, Hokaku H, Takei A: Fluorescence automatic cell sorter and immunohistochemical investigation of CD68-positive cells in meningioma. Clin Neurol Neurosurg 101:229-234, 1999.
3. Becker I, Roggendorf W: Immunohistological investigation of mononuclear cell infiltrates in meningiomas. Acta Neuropathol (Berl) 79:211-216, 1989.
4. Bø L, Mørk SJ, Nyland H: An immunohistochemical study of mononuclear cells in meningiomas. Neuropathol Appl Neurobiol 18:548-558, 1992.
5. Boyle EA, McGeer PL: Cellular immune response in multiple sclerosis plaques. Am J Pathol 137:575-584, 1990.
6. Braun DP, Penn RD, Harris JE: Regulation of natural killer cell function by glass-adherent cells in patients with primary intracranial malignancies. Neurosurgery 15:219-224, 1984.
7. Buhl R, Hugo HH, Mihajlovic Z, Mehdorn HM: Secretory meningiomas: Clinical and immunohistochemical observations. Neurosurgery 48:297-302, 2001.
8. Challa VR, Moody DM, Marshall RB, Kelly DL Jr: The vascular component in meningiomas associated with severe cerebral edema. Neurosurgery 7:363-368, 1980.
9. Colakoglu N, Demirtas E, Oktar N, Yüntem N, Islekel S, Özdamar N: Secretory meningiomas. J Neurooncol 62:233-241, 2003.
10. Frei K, Piani D, Malipiero UV, Van Meir E, de Tribolet N, Fontana A: Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells: Despite the presence of inducing signals GM-CSF is not expressed in vivo. J Immunol 148:3140-3146, 1992.
11. Fries G, Perneczky A, Kempski O: Glioblastoma-associated circulating monocytes and the release of epidermal growth factor. J Neurosurg 85:642-647, 1996.
12. Graeber MB, Bise K, Mehraein P: CR3/43, a marker for activated human microglia: Application to diagnostic neuropathology. Neuropathol Appl Neurobiol 20:406-408, 1994.
13. Hinton DR, Kovacs K, Chandrasoma PT: Cytologic features of secretory meningioma. Acta Cytol 43:121-125, 1999.
14. Kepes JJ: Observation on the formation of psammoma bodies and pseudopsammoma bodies in meningiomas. J Neuropathol Exp Neurol 34:282-289, 1961.
15. Kreutzberg GW: Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318, 1996.
16. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ: Meningiomas, in Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System. Lyon, IARC Press, 2000, pp 176-184.
17. Morantz RA, Wood GW, Foster M, Clark M, Gollahon K: Macrophages in experimental and human brain tumors: Part 2-Studies of the macrophage content of human brain tumors. J Neurosurg 50:305-311, 1979.
18. Nishio S, Morioka T, Suzuki S, Hirano K, Fukui M: Secretory meningioma: Clinicopathologic features of eight cases. J Clin Neurosci 8:335-339, 2001.
19. Probst-Cousin S, Villagran-Lillo R, Lahl R, Bergmann M, Schmid KW, Gullotta F: Secretory meningioma. Cancer 79:2003-2015, 1997.
20. Roggendorf W, Strupp S, Paulus W: Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol (Berl) 92:288-293, 1996.
21. Rossi ML, Cruz Sanchez F, Hughes JT, Esiri MM, Coakham HB: Immunocytochemical study of the cellular immune response in meningiomas. J Clin Pathol 41:314-319, 1988.
22. Schelper RL, Beck DW, Boarini DJ, Hart MN, Baumbach GL: Proteins of hyaline inclusions in meningioma. J Neuropathol Exp Neurol 43:297, 1984.
23. Schneider J, Hofman FM, Apuzzo MLJ, Hinton DR: Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg 77: 265-273, 1992.
24. Shinonaga M, Chang CC, Suzuki N, Sato M, Kuwabara T: Immunohistological evaluation of macrophages infiltrates in brain tumors. J Neurosurg 68:259-265, 1988.
25. Smits HA, van Beelen AJ, de Vos NM, Rijsmus A, Vehroef J, van Muiswinkel FL, Nottet HS: Activation of human macrophages by amyloid-β is attenuated by astrocytes. J Immunol 166:6869-6876, 2001.
26. Streit WJ, Kincald-Colton CA: The brain's immune system. Sci Am 273: 54-61, 1995.
27. Tran CT, Wolz P, Egensperger R, Kosel S, Imai Y, Bise K, Koshaka S, Mehraein P, Graeber MB: Differential expression of MHC class II molecules by microglia and neoplastic astroglia: Relevance for the escape of astrocytoma cells from immune surveillance. Neuropathol Appl Neurobiol 24:293-301, 1998.